| Inventor | Institute |
|---|---|
| Marta Martins | Instituto de Medicina Molecular João Lobo Antunes |
| SKU: | 161945 |
|---|---|
| Product description: | For stable PLCG1 overexpression (SW48-PLCG1), SW48 cells were infected with PLCG1 lentiviral activation particles (Santa Cruz Biotechnology). Selection of stable clones started 2 days after infection with a mix of 2 ?g/mL Puromycin, 50 mg/mL Hygromicyn B, and 10 mg/mL Blasticidin. |
| Gender: | Male |
| CRISPR: | No |
| Parental cell line: | SW480 |
| Disease: | Cancer |
| Cat. #: | 161945 |
|---|---|
| Cancer types: | Colorectal cancer |
| Research Fields: | Cancer |
| Organism: | Human |
| Tissue: | Epithelial |
| Gender: | Male |
| Model: | Over-expression |
| Growth properties: | A subcultivation ratio of 1:4 to 1:6 is recommended, 1 to 2 times per week. |
| Primary citation: | Martins, et al. 2022. Clin Cancer Res. 28(6):1203-1216. PMID: 34980600 |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry Ice |
| Growth medium: | DMEM with 10% FBS, 5% CO2 |
| Recommended controls: | shRNA scrambled control |
| Biosafety level: | 1 |
| References: |
Martins, et al. 2022. Clin Cancer Res. 28(6):1203-1216. PMID: 34980600 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.